Trial intelligence / Profile preview

Niclosamide in Diabetic Kidney Disease

NCT04317430Phase 3Completed

Sponsor
Tanta University
Start
Feb 2020
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of niclosamide in diabetic nephropathy (DN), sponsored by Tanta University. Started Feb 2020; status: completed.

02

Drugs

niclosamide
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT04317430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04317430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call